0001209191-19-007864.txt : 20190206
0001209191-19-007864.hdr.sgml : 20190206
20190206181814
ACCESSION NUMBER: 0001209191-19-007864
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190205
FILED AS OF DATE: 20190206
DATE AS OF CHANGE: 20190206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TEVANIAN AVADIS
CENTRAL INDEX KEY: 0001214091
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 19573012
MAIL ADDRESS:
STREET 1: APPLE COMPUTER INC
STREET 2: 1 INFINITE LOOP
CITY: CUPERTINO
STATE: CA
ZIP: 95014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0924
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-05
0
0001308547
Dolby Laboratories, Inc.
DLB
0001214091
TEVANIAN AVADIS
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
1
0
0
0
Class A Common Stock
2019-02-05
4
A
0
3996
0.00
A
3996
D
Class A Common Stock
2019-02-05
4
S
0
1960
65.00
D
46750
I
By Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996
Award represents a total of 3,996 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Each unit represents a
contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2020 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.
Shares held following the reported transactions include 3,996 restricted stock units, which are subject to forfeiture until they vest.
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
/s/ Daniel Rodriguez, as Attorney-in-Fact for Avadis Tevanian
2019-02-06